HomeORIC • NASDAQ
add
ORIC Pharmaceuticals Inc
Previous close
$7.96
Day range
$7.92 - $8.82
Year range
$6.33 - $16.63
Market cap
576.53M USD
Avg Volume
401.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.32M | 33.60% |
Net income | -34.57M | -35.67% |
Net profit margin | — | — |
Earnings per share | -0.49 | -11.36% |
EBITDA | -38.05M | -33.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 272.37M | 19.83% |
Total assets | 302.07M | 10.11% |
Total liabilities | 28.08M | 4.29% |
Total equity | 273.99M | — |
Shares outstanding | 70.57M | — |
Price to book | 2.05 | — |
Return on assets | -30.36% | — |
Return on capital | -32.14% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -34.57M | -35.67% |
Cash from operations | -28.80M | -46.59% |
Cash from investing | 23.07M | 139.89% |
Cash from financing | 126.00K | 306.45% |
Net change in cash | -5.60M | 92.77% |
Free cash flow | -16.55M | -61.65% |
About
Founded
2014
Headquarters
Website
Employees
112
